PPV for CRC | PPV for AN† | Detection rate for CRC | Detection rate for AN† | |||||||||||||
% | OR | 95% CI | % | OR | 95% CI | % | OR | 95% CI | % | OR | 95% CI | |||||
A. Invitation period | ||||||||||||||||
Before | 5.3 | Ref | 34.7 | Ref* | 0.19 | Ref | 1.25 | Ref | ||||||||
During | 4.6 | 0.91 | 0.81 | 1.1.03 | 31.8 | 0.91 | 0.86 | 0.96 | 0.16 | 0.90 | 0.80 | 1.01 | 1.09 | 0.92 | 0.88 | 0.96 |
After | 4.2 | 0.91 | 0.84 | 0.99 | 32.0 | 0.95 | 0.92 | 0.98 | 0.14 | 0.92 | 0.85 | 0.99 | 1.07 | 0.97 | 0.94 | 1.00 |
B. Invitation interval (months) | ||||||||||||||||
≤24–25 | 5.1 | Ref | 33.9 | Ref | 0.18 | Ref | 1.20 | Ref | ||||||||
25–26 | 4.7 | 1.02 | 0.89 | 1.17 | 32.9 | 1.02 | 0.96 | 1.09 | 0.16 | 1.04 | 0.92 | 1.19 | 1.11 | 0.78 | 0.75 | 1.09 |
26–27 | 4.6 | 1.01 | 0.89 | 1.14 | 31.9 | 1.01 | 0.96 | 1.07 | 0.15 | 1.02 | 0.91 | 1.15 | 1.07 | 1.04 | 0.99 | 1.07 |
27–28 | 3.9 | 0.89 | 0.77 | 1.02 | 31.3 | 0.98 | 0.92 | 1.04 | 0.13 | 0.93 | 0.81 | 1.07 | 1.06 | 1.02 | 0.98 | 1.08 |
28–29 | 4.1 | 0.89 | 0.74 | 1.08 | 33.4 | 1.05 | 0.97 | 1.14 | 0.14 | 0.94 | 0.78 | 1.13 | 1.15 | 1.02 | 0.97 | 1.16 |
>29 | 4.3 | 0.92 | 0.72 | 1.17 | 32.8 | 1.04 | 0.94 | 1.15 | 0.28 | 0.94 | 0.74 | 1.19 | 2.16 | 1.09 | 1.02 | 1.13 |
All ORs are adjusted for confounding variables age, sex and invitation round.
*Ref indicates that the alternative model (including the time period) better fitted the data. All ORs are presented for the alternative model including time period, regardless if it improved the model.
†AN is the combination of colorectal cancer and advanced neoplasia.
AN, advanced neoplasia; CRC, colorectal cancer; PPV, positive predictive value.